Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Lupin receives two FDA approvals and share price jumps

Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...

Clovis Oncology shares plummeted this week

Following the release of its first-quarter results and operational update, Clovis Oncology's shares traded down sharply. According to data provided by S&P Global Market...

Biogen invests $120 million in MedRhythms, a music therapy for multiple sclerosis

Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment...

PepGen announces pricing of initial public stock offering

PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...

FDA restricts J&J’s COVID-19 vaccine on blood clot risks

The Food and Drug Administration is limiting the use of the J&J shot, which received U.S. clearance in February 2021. In a statement released on...

BMS, Merck enter into $2.3 billion partnership with Amphista to discover and develop small molecule protein degraders

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, May 4th announced a strategic collaboration...
spot_img

Expert Articles

spot_img